Trial: 201709201

Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma

Phase

II

Principal Investigator

Kahl, Brad

Disease Site

Non-Hodgkin’s Lymphoma

Learn more about this study at: clinicaltrials.gov